CQDM and CIHR fund two promising personalized medicine research collaborations

From left to right, Jane Aubin, Chief Scientific Officer and Vice-President, Research and Knowledge Translation at the Canadian Institutes of Health Research (CIHR); Diane Gosselin, President and CEO of CQDM and Étienne Richer, Assistant Director, CIHR Institute of Genetics.

From left to right, Jane Aubin, Chief Scientific Officer and Vice-President, Research and Knowledge Translation at the Canadian Institutes of Health Research (CIHR); Diane Gosselin, President and CEO of CQDM and Étienne Richer, Assistant Director, CIHR Institute of Genetics.

Montreal, QC – CQDM and CIHR, through its institutes of Cancer Research, Genetics and Infection and Immunity, are kicking in $1.5 million in funding for two translational projects in personalized medicine.

Please Login to view this Content. (Not a member? Join Today!)
Password Reset
Please enter your e-mail address. You will receive a new password via e-mail.